Changes in energy metabolism in pheochromocytoma

J Clin Endocrinol Metab. 2013 Apr;98(4):1651-8. doi: 10.1210/jc.2012-3625. Epub 2013 Feb 22.

Abstract

Context: Catecholamine overproduction in pheochromocytoma affects basal metabolism, resulting in weight loss despite normal food intake.

Objective: The objective of the study was to evaluate changes in energy metabolism expressed as resting energy expenditure (REE) in patients with pheochromocytoma before and after adrenalectomy and the possible relationship with circulating inflammatory markers.

Design: We measured REE in 17 patients (8 women) with pheochromocytoma by indirect calorimetry (Vmax-Encore 29N system) before and 1 year after adrenalectomy. Body fat percentage was measured with a Bodystat device. Inflammatory markers (leukocytes count and C-reactive protein) and cytokines (TNF-α, IL-6, and IL-8) were analyzed with a Luminex 200.

Results: REE measured in the pheochromocytoma group was 10.4% higher than the predicted value (1731 ± 314 vs 1581 ± 271 kcal/d; P = .004). Adrenalectomy significantly increased body mass index (P =0.004) and the percentage of body fat (P = .01), with a proportional increase in fat distribution (waist circumference, P = .045; hip circumference, P = .001). REE significantly decreased after adrenalectomy (1731 ± 314 vs 1539 ± 215 kcal/d; P = .002), even after adjustments in body surface and body weight (P < .001). After adrenalectomy, we found a significant decrease in leukocyte counts (P = .014) and in the levels of TNF-α (P < .001), IL-6 (P = .048), and IL-8 (P = .007) but not C-reactive protein (P = .09). No significant correlations among calorimetry parameters, hormones, and proinflammatory markers were detected.

Conclusions: Chronic catecholamine overproduction in pheochromocytoma may lead to a proinflammatory and hypermetabolic state characterized by increased REE. Adrenalectomy leads to the normalization of energy metabolism followed by an increase in body mass index and body fat content and decreases in inflammatory markers and cytokines.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipose Tissue / drug effects
  • Adipose Tissue / pathology
  • Adrenal Gland Neoplasms / metabolism*
  • Adrenal Gland Neoplasms / pathology
  • Adrenal Gland Neoplasms / surgery
  • Adrenalectomy / rehabilitation
  • Adult
  • Aged
  • Basal Metabolism / drug effects
  • Basal Metabolism / physiology
  • Body Composition / drug effects
  • Body Composition / physiology
  • Body Weight / drug effects
  • Body Weight / physiology
  • Catecholamines / blood
  • Catecholamines / metabolism
  • Catecholamines / pharmacology
  • Energy Metabolism / drug effects
  • Energy Metabolism / physiology*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Organ Size / drug effects
  • Pheochromocytoma / metabolism*
  • Pheochromocytoma / pathology
  • Pheochromocytoma / surgery

Substances

  • Catecholamines